1346600-86-9
1346600-86-9
Chemical Structure
Methocarbamol-d3
- CAS No.: 1346600-86-9
- Formula:C11H12D3NO5
- Molecular Weight:244.26
IUPAC Name: 2-hydroxy-3-(2-(methoxy-d3)phenoxy)propyl carbamate
InChIKey: GNXFOGHNGIVQEH-FIBGUPNXSA-N
SMILES: O(CC(COC(N)=O)O)C1=C(OC([2H])([2H])[2H])C=CC=C1
Biological Activity: Methocarbamol-d3 is the deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Methocarbamol-d3 | 98.15% | Methocarbamol-d3 is the deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methocarbamol (Standard) | ≥98% | Methocarbamol (Standard) is the analytical standard of Methocarbamol. This product is intended for research and analytical applications. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methocarbamol-13C,d3 | Methocarbamol-13C,d3 is the 13C- and deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methocarbamol-d5 | Methocarbamol-d5 is deuterium labeled Methocarbamol. Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methocarbamol | 99.68% | Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Bruce, R.B., L.B. Turnbull, and J.H. Newman, Metabolism of methocarbamol in the rat, dog, and human. J Pharm Sci, 1971. 60(1): p. 104-6. [Content Brief]
- [3]. Sica, D.A., et al., Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Eur J Clin Pharmacol, 1990. 39(2): p. 193-4. [Content Brief]
